EDS [Exceed Co] SC 13E3/A: (Original Filing)
[]
JMEI [Jumei International] F-6: (Original Filing)
[] [] [Writer’s Direct Dial Emmet, Marvin & Martin, LLP Counsellors at Law _____ 120 Broadway New York, New York 10271 _____ (212) 238-3000 (212) 653-1760 _____ Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.emmetmarvin.com 177 Madison Avenue Morristown, New Jersey 07960 (973) 538-5600 Fax: (973) 538-6448 May 6, 2014 The Bank of New York Mellon, as Depositary 101 Barclay Street New York,]
BABA [Alibaba] CORRESP: (Original Filing)
[IMPSON HACHER ARTLETT S MERICAN AWYERS A OWER TH LOOR ICBC T ARDEN OAD 3 G ONG ONG H (852) 2514-7600 ACSIMILE F IRECT IAL UMBER D +852 2514 7630 AIL DDRESS E-M lchen@stblaw.com May 6, 2014 VIA EDGAR Division of Corporation Finance 100 F Street, N.E. Re: Alibaba Group Holding Limited Registration Statement on Form F-1 CIK No.: 0001577552]
CBPO [China Biologic Products] 8-K: (Original Filing)
[FOR RELEASE May 6, 2014 China Biologic Reports Financial Results for the First Quarter of 2014 1Q14 Total Sales Increase 4.1% to $56.3Million 1Q14 Operating Margin Increases to 49.7% from 1Q14 Non-GAAP Net Income Increases 16.3% to $ 19.1Million BEIJING, China – May 6, 2014 – First Quarter 2014 Financial Highlights · Total sales · Gross profit · Income from] []
TOUR [Tuniu] CORRESP: (Original Filing)
[Morgan Stanley & Co. International plc Credit Suisse Securities (USA) LLC China Renaissance Securities (Hong Kong) Limited 25 Cabot Square, Canary Wharf London E14 4QA United Kingdom Eleven Madison Avenue New York, New York 10010-3629 U.S.A. Unit 901, Agricultural Bank of China Tower 50 Connaught Road Central, Central Hong Kong VIA EDGAR AND FACSIMILE May 6, 2014 Division of Corporation]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT April 30, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8551-6696 o o o]
CBPO [China Biologic Products] 10-Q: (Original Filing)
[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]
CHLN [China Housing & Land Development] 8-K: (Original Filing)
[Resignation Letter of Mr. Heung Sang Fong 发件人 : dexterfong0@gmail.com 日期 : 年 月 日 收件人 : nicolalu@gmail.com 抄送 : cangsang@gmail.com 主题 : My resignation Jing: Please accept this email as my formal resignation from the position of directorship of the company due to personal reasons. My resignation will be effective as of May 1, 2014. It has been my] []
TOUR [Tuniu] CORRESP: (Original Filing)
[KADDEN RPS LATE EAGHER LOM S ARTNERS P OHN DEBIYI ¿ J HRISTOPHER ETTS C DWARD AM ¿ E AUL ITCHARD ¿ G.S. P LIVE OUGH ¿ C ONATHAN TONE J LEC RACY A ¿ LSO DMITTED IN NGLAND ALES LSO DMITTED IN EW ORK * (A EGISTERED OREIGN AWYERS R ILL AI ALIFORNIA W ULIE AO ALIFORNIA Z. J]
TOUR [Tuniu] F-1/A: (Original Filing)
[PROSPECTUS (Subject to Completion) Issued May 6, 2014 8,000,000 American Depositary Shares Tuniu Corporation REPRESENTING 24,000,000 CLASS A ORDINARY SHARES US$ US$ US$ Tuniu Corporation is offering 7,380,000 American depositary shares, or ADSs, and the selling shareholders are offering 620,000 ADSs. Each ADS represents three Class A ordinary shares, par value US$ Upon completion of this offering, we will have] [[8,000,000] American Depository Shares Each Representing Three Class A Ordinary Shares, Par Value US$0.0001 Per Share TUNIU CORPORATION UNDERWRITING AGREEMENT Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, N.Y. 10010 China Renaissance Securities (Hong Kong) Limited Unit 901, Agricultural Bank of China] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the use in this Registration Statement on Form F-1 of Tuniu Corporation of our report dated March 6, 2014, except for the stock option grant, the adoption of the 2014 Share Incentive Plan, the private placement and the modifications to the Companys Memorandum and Articles of Association and Series]
